Two new glaucoma preparations in preservative-free multi-dose bottles

Eydelto (dorzolamide) and Eylamdo (dorzolamide/timolol) are presented in a unique multi-dose device differentiating them from existing preservative-free products, which are available only as single-dose vials.

The drops are presented in an easy-to-squeeze bottle which is also designed to assist aim and dispense one drop at a time. | SCIENCE PHOTO LIBRARY
The drops are presented in an easy-to-squeeze bottle which is also designed to assist aim and dispense one drop at a time. | SCIENCE PHOTO LIBRARY

The bottle features a dropper with a one-way valve to ensure that no contaminated liquid can be reintroduced after a drop has been dispensed, removing the need for preservatives and preventing bacterial contamination over the 28-day in-use shelf-life.

In addition, silver is incorporated within the nozzle top and cap to prevent bacterial contamination of any residual solution which may remain on the tip. As a result Eydelto and Eylamdo should not be used in patients with a history of contact hypersensitivity to silver.

Eydelto contains 20mg/ml dorzolamide and is indicated for use as monotherapy where β-blockers are ineffective or contraindicated, or as an adjunct to β-blockers in adults with ocular hypertension, open-angle or pseudoexfoliative glaucoma.

Eylamdo contains 20mg/ml dorzolamide and 5mg/ml timolol. It indicated for the treatment of raised intraocular pressure in adults with open-angle or pseudoexfoliative glaucoma when β-blocker monotherapy is inadequate.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more